Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactions. - Wikidata - wikimedia - TriplyDB

Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactions.

Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactions.

http://www.wikidata.org/entity/Q37027004

about

Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer.Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions.Functional gene variants of CYP3A4.

P2860

Q36702536-99C701FA-595F-4479-B050-C62885580C77 Q37130938-54892BF6-C960-4FE8-B4D2-2A3B6D96CF2F Q38220008-1FA66D7B-7167-4D2D-B45D-F3246B57C132

P2860

Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactions.

http://www.wikidata.org/entity/Q37027004

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of CYP3A5 expression on ...... diated drug-drug interactions.

@en

Effect of CYP3A5 expression on ...... diated drug-drug interactions.

@nl

type

label

Effect of CYP3A5 expression on ...... diated drug-drug interactions.

@en

Effect of CYP3A5 expression on ...... diated drug-drug interactions.

@nl

prefLabel

Effect of CYP3A5 expression on ...... diated drug-drug interactions.

@en

Effect of CYP3A5 expression on ...... diated drug-drug interactions.

@nl

P1433

Q37027004-23F31127-CCDE-4C38-8CD0-C2B1D91E70BE

P1476

Q37027004-46588E4E-9DC1-4880-AD0D-04600E83F11A

P2093

Q37027004-28087DFA-F173-4484-A2BF-A84FAA1606D7

Q37027004-3E945852-5B71-4E2B-BC15-2785F716B26E

Q37027004-55D9C327-D867-48D8-8B36-EFDF0CEF0CC4

Q37027004-6AD8ECA7-0BF0-4DBB-8805-FF1DE267D85E

Q37027004-9B6B1F36-D038-48C3-ACAF-9B073F4E178A

Q37027004-B032A99B-6EBA-43C2-9FE4-A49FF3532A48

Q37027004-DD85D9DA-6195-43D3-8DFA-8785557B3C57

P2860

Q37027004-0A403EE2-FA51-47F6-8C0A-93118B42A103

Q37027004-0ACE2784-435C-4A5D-9E1F-0BB614E5D301

Q37027004-111D9BF2-CE42-4642-A77A-647109C9F394

Q37027004-14CD06BD-3224-4CA2-A23F-AE638D6986D1

Q37027004-1A580860-BDD6-48F8-B5C0-C8F40E00F869

Q37027004-1ED66228-DE0A-4776-A76B-4682DD4BAC28

Q37027004-25A47DB9-53C6-4BA3-B7CD-64C43F307C62

Q37027004-282A4BCF-62ED-4948-BCE9-297410981F0C

Q37027004-28D91633-D2BA-4A01-BFBB-144590DBE2B1

Q37027004-2FC57111-DB8E-408C-86B5-2B33A6BF14D0

P304

Q37027004-6259A7C1-7DE8-4EFC-85CF-A4291B59506F

P31

Q37027004-7A7E49F2-A007-4F4B-ABF3-427033278B9F

P356

Q37027004-77343F2F-E2AE-45A2-922B-0589F315E938

P433

Q37027004-B2B05892-7316-4676-9649-1BEB8CA70B60

P478

Q37027004-CEFD84A5-4A58-4419-98F9-66AD08FDA29F

P577

Q37027004-34242E38-4FA5-4B07-B890-E4EEA8874CDB

P5875

Q37027004-F5FCB062-9F74-466F-9CBF-436EF57D371A

P698

Q37027004-0D346DC5-5327-405E-9DD2-AE5E8C63FCE2

P932

Q37027004-5D97E940-579B-4BDB-B96E-B64E78FC65CF

P356

P1433

Drug Metabolism and Disposition

P1476

Effect of CYP3A5 expression on ...... diated drug-drug interactions.

@en

P2093

A David Rodrigues

http://www.w3.org/2001/XMLSchema#string

Chi-Chi Peng

http://www.w3.org/2001/XMLSchema#string

Kenneth E Thummel

http://www.w3.org/2001/XMLSchema#string

Mary F Grubb

http://www.w3.org/2001/XMLSchema#string

Nina Isoherranen

http://www.w3.org/2001/XMLSchema#string

Shu-Ying Chang

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Shirasaka

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic contribution to variable human CYP3A-mediated metabolism

Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test

Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Selective metabolism of vincristine in vitro by CYP3A5.

Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects.

Stereochemical aspects of itraconazole metabolism in vitro and in vivo.

Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.

Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.

In vitro and in vivo drug interactions involving human CYP3A.

Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics

P304

1566-1574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.112.049940

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236977915

http://www.w3.org/2001/XMLSchema#string

P698

23723360

http://www.w3.org/2001/XMLSchema#string

P932

3716306

http://www.w3.org/2001/XMLSchema#string